Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT

Clinical trial NCT07166445 · RECRUITING

Trial details

NCT number: NCT07166445
Sponsor: Peking University First Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Carcinoma, Renal Cell Diagnostic Imaging Pathology Deep Learning

Start date: 2024-09-01
Primary completion: 2025-12-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.